TITLE

MATRITECH/SYSMEX TO DEVELOP AUTOMATED PAP SMEAR TEST

PUB. DATE
January 2003
SOURCE
Worldwide Biotech;Jan2003, Vol. 15 Issue 1, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the partnership between Matritech Inc. and Sysmex Corp. to develop an automated Pap smear test.
ACCESSION #
8775101

 

Related Articles

  • Agreements/contracts.  // Medical Device Daily;7/13/2010, Vol. 14 Issue 134, p3 

    The article reports on a three-year, dual source urinalysis contract agreement of Sysmex with Amerinet which allows Amerinet members to have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls and service.

  • Product Briefs.  // Medical Device Daily;4/5/2010, Vol. 14 Issue 64, p9 

    The article previews the Sysmex XT-4000i Automated Hematology Analyzer from Sysmex.

  • Advance with automation.  // MLO: Medical Laboratory Observer;Nov2001, Vol. 33 Issue 11, p40 

    Presents the Sysmex XE-2000, an automated hematology analyzer from Sysmex Corp. Key features.

  • Sysmex Begins Joint Development of Imaging FCM Products with Merck.  // Medical Buyer;3/31/2016, p1 

    The article announces that hematology instrumentation supplier Sysmex and pharmaceutical company Merck's life science business have begun developing an automated system for FISH testing using imaging FCM technology, based on their joint clinical research on hematologic disorders potential.

  • Data Presented at American Urological Association Annual Meeting Highlights Superior Performance of Matritech's NMP22 BladderCheck Test.  // Journal of Oncology Management;Jul/Aug2004, Vol. 13 Issue 4, p24 

    Reports on the presentation of results of an independent study involving Matritech Inc.'s NMP22 BladderCheck Test at the American Urological Association Annual Meeting in San Francisco, California. Utility of the test to detect bladder cancer in both symptomatic patients with no prior history of...

  • As I see it. Dodgson, Gregory E.V. // Grand Rapids Business Journal;04/07/97, Vol. 15 Issue 14, p15 

    Analyzes the investment potentials of Massachusetts-based Matritech Inc., producer of blood-based colon cancer detection assay. Shipping of the test kit to accounts outside the United States; Estimated value of tests in the medical market.

  • Japan gets analysis distribution rights.  // Dairy Industries International;Nov98, Vol. 63 Issue 11, p47 

    Reports that Malvern Instruments has concluded an agreement with Japanese company Sysmex Corp. giving Sysmex exclusive distribution rights in Japan for Malvern's range of laboratory-based particle analyzers. Background information on the move; Other information on the company.

  • spotlight.  // Clinical Lab Products;Jul2013, Vol. 43 Issue 7, p30 

    The article offers a preview of the track and manage software CLIN 1 - QC from Clinical Software Solutions, the middleware software platform Sysmex WAM Select from Sysmex and the connectivity tool Orchard Copia from Orchard Software.

  • Sysmex, bioMérieux agree to new Japanese joint venture.  // Medical Device Daily;1/17/2008, Vol. 12 Issue 12, p1 

    The article reports on an agreement signed by Sysmex and bioMérieux by which Sysmex will take a 34 percent equity stake in bioMérieux Japan. The new company formed under the agreement will be called Sysmex bioMérieux Co. Ltd. and will promote and commercialize the entire bioMérieux...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics